Uwell Biopharma, Inc. (TPEX: 7902)
Health Care · Biotechnology · TW
NT$28.00
-4.92% today · +1.4% 1Y
Uwell Biopharma, Inc. (TPEX: 7902) operates in the Biotechnology industry within the Health Care sector. The company is valued at $175.67M.
Over the last twelve months the share price has gained 1.4%, trading between 7.80 and 51.50.
Tweenvest scores Uwell Biopharma, Inc. across four factors: quality 38/100, value 77/100. Its strongest factor is value.
7902 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $175.67M
- Revenue (TTM)
- $1.10K
- P/E
- —
- EPS
- -0.37
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$51.50
- 52-week low
- NT$7.80
- Avg volume (3M)
- —
- Shares outstanding
- 200.60M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Precision BioSciences, Inc.NasdaqCM: DTIL | $180.24M | $6.53 | -2.83% |
| Hester Biosciences LimitedBSE: 524669 | $179.48M | Rs2,041.90 | -4.61% |
| Compass Therapeutics, Inc.NasdaqCM: CMPX | $178.83M | $0.94 | -5.59% |
| Cue Biopharma, Inc.NasdaqCM: CUE | $178.78M | $24.61 | -11.03% |
| ALX Oncology Holdings Inc.NasdaqGS: ALXO | $174.23M | $1.26 | +0.80% |
| GC Genome CorporationKOSDAQ: A340450 | $173.64M | ₩9,870.00 | +11.15% |
| TYK Medicines, IncSEHK: 2410 | $173.28M | HK$3.54 | -17.79% |
| PepGen Inc.NasdaqGS: PEPG | $172.46M | $2.49 | -4.96% |
Figures last refreshed Oct 11, 2026.